authors
- Sridhar, SS
- Hotte, Sebastien
- Mackenzie, MJ
- Kollmannsberger, C
- Haider, MA
- Pond, Gregory
- Chen, EX
- Srinivasan, R
- Ivy, SP
- Moore, MJ
Phase II study of the angiogenesis inhibitor AZD2171 in first line, progressive, unresectable, advanced metastatic renal cell carcinoma (RCC): A trial of the PMH Phase II Consortium
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2007
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal